Bivin & Associates’s Organon & Co OGN Stock Holding History

Bivin & Associates’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$2K	Hold	60	–	–	﹤0.01%	230
2022 Q1	$2K	Hold	60	–	–	﹤0.01%	249
2021 Q4	$2K	Buy	+60	New	+$1.95K	﹤0.01%	257

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bivin & Associates's OGN Position: Q2 2022 in Review

Bivin & Associates held its Organon & Co (OGN) position steady in Q2 2022 at 60 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #230.

Bivin & Associates first reported a position in OGN in Q4 2021 and has held it in 3 quarters since. 853 funds tracked by Wall St. Rank hold OGN as of Q2 2022.

Bivin & Associates held 60 shares of Organon & Co worth $2K as of Q2 2022.
Bivin & Associates left its Organon & Co share count unchanged in Q2 2022.
Organon & Co made up ﹤0.01% of Bivin & Associates's portfolio in Q2 2022, its #230 holding.
Bivin & Associates first reported a position in Organon & Co in Q4 2021 and has held it in 3 quarters since.
853 funds tracked by Wall St. Rank held Organon & Co as of Q2 2022.

Based on Bivin & Associates's 13F filing for Q2 2022, filed 11 Aug 2022.